Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription.
about
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaShort-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsInterventions to improve antibiotic prescribing practices for hospital inpatientsDe-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shockDe-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shockShort-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsQ24240274Antibiotics for ventilator-associated pneumoniaInterventions to improve antibiotic prescribing practices for hospital inpatientsCombating antimicrobial resistance: policy recommendations to save livesOptimizing antibiotic therapy in the intensive care unit setting.Cost effectiveness in treating ventilator-associated pneumoniaPro/con clinical debate: the use of a protected specimen brush in the diagnosis of ventilator associated pneumonia.Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.How to educate prescribers in antimicrobial stewardship practicesVentilator-associated pneumonia in the ICUAntimicrobial Stewardship: How the Microbiology Laboratory Can Right the ShipVentilator-associated pneumonia: diagnosis, treatment, and preventionAntimicrobial stewardship: philosophy versus practice.Oseltamivir overuse at a Chicago hospital during the 2009 influenza pandemic and the poor predictive value of influenza-like illness criteria.Antibiotic stewardship in the intensive care unit.Comparative impact of guidelines, clinical data, and decision support on prescribing decisions: an interactive web experiment with simulated cases.Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data.Ventilator-associated pneumonia: problems with diagnosis and therapyProcalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit.A randomised controlled comparison of early post-pyloric versus early gastric feeding to meet nutritional targets in ventilated intensive care patients.Identifying missed opportunities to curtail antimicrobial therapy for presumed ventilator-associated pneumonia using the clinical pulmonary infection score.Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shockA week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia.Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational studyPro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit?Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineAppraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trialRecommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.Critical analysis of empiric antibiotic utilization: establishing benchmarks.
P2860
Q22241905-4153580A-F87F-4F73-8748-7BC25342BAB7Q24187768-B636C49B-35C6-4FF4-BB50-058DA711E020Q24197807-3E293204-7D76-4A4C-AC79-407D3324E106Q24198268-86440BAB-D031-48EF-8F11-5B5A969997C1Q24235566-8C973004-0C1D-4276-B2D0-80C2B92941F3Q24236108-0FB5A0F4-1977-4ECE-89E9-BB0CC97DBEE5Q24240274-A8F453D7-4FE1-49EA-8EBB-AF9AE42C614DQ24240904-385B2789-E207-44D4-B285-87CB55245D38Q24245936-FEE134B5-4A86-426B-8949-F84E62420138Q24632857-5B722CF7-4AF7-467D-AC76-2C5270355D02Q24796204-7F658F37-C0FB-4F2C-ACCA-00DB27FC91B2Q24796271-7F12B368-7FBC-44E4-8AB7-12581486DF54Q24796504-FF3D52F9-7009-4B43-9326-418D4D928601Q24813204-82FC34E2-8F0A-4E52-960F-7DD59F53271CQ26851384-E169DD1B-9D42-4D9D-93C4-D87F627478C4Q26862843-5FD2B433-D465-44C5-82DD-70DB213D52E6Q28068503-509A399B-551F-4A65-855E-8826B32ACD79Q29012676-74C2CC00-C0CF-4785-9B55-973F07671003Q30367226-D9FD1359-4F4D-41B3-8A9A-F709CAC2E402Q30408617-3F37CFBC-88A8-47D8-BF65-9F609D3E0E83Q30408712-D07C8C0F-D122-4E60-9665-7A2C8B017183Q30881615-CFF04EA9-F013-4500-A549-C458EAECEC2EQ31122362-2F652491-5705-43C4-9723-77B23CDC3909Q33373424-6B96F2C2-F8D8-4F19-903A-0D1E23B65FC1Q33378956-FC2952D0-203E-4FAC-B5F5-D8116B94D967Q33539217-8FB4FC82-EA0E-4D8F-8E2A-5BBA078A2D48Q33606858-39435BB2-CB01-432B-A5BD-18F93591B10DQ33612657-190B45F1-CEBA-4BD7-A4F0-817402610E4BQ33681164-78EE5484-62BF-41F7-AB97-064C7C798838Q33750023-1A9A8639-A813-4D6C-8499-CFF6DE9E2211Q33753745-9AA6BEA1-CE9E-42FA-B4F4-37F6EC4268F2Q33770046-93EABDC9-6C03-4E0D-BB9F-782EA84CF4DEQ33821978-701B9EC7-700E-418F-9037-EE84BEB719BCQ33873338-5B500C6B-DB7A-4F43-8CD7-FDE24C61C437Q33974292-28BC12EE-12C0-4D21-9C74-88A4A773EFEDQ34003193-98685BB8-33FC-405C-BC1C-604ECCED70BCQ34014835-8C04DD51-25CF-41E3-83DA-DFDD4753AEDEQ34017829-245EE268-70C2-416A-8244-67B472D2C23CQ34165319-41B50AA9-4561-40C4-80CD-C06D0B0C9DDEQ34207396-259C568C-5C65-4FD2-96DE-21BE344A6D46
P2860
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Short-course empiric antibioti ...... inate antibiotic prescription.
@ast
Short-course empiric antibioti ...... inate antibiotic prescription.
@en
type
label
Short-course empiric antibioti ...... inate antibiotic prescription.
@ast
Short-course empiric antibioti ...... inate antibiotic prescription.
@en
prefLabel
Short-course empiric antibioti ...... inate antibiotic prescription.
@ast
Short-course empiric antibioti ...... inate antibiotic prescription.
@en
P2093
P921
P1476
Short-course empiric antibioti ...... inate antibiotic prescription.
@en
P2093
P304
P356
10.1164/AJRCCM.162.2.9909095
P407
P433
P577
2000-08-01T00:00:00Z